Inflammation and Oxidative Damage in Fatty Acids Oxidation Disorders
Cell Biochemistry and Function · 2026-11 · 44 (11)
DOI: 10.1002/cbf.70328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Function, online erschienen am 03.11.2026. Verfasst von Stefani Altenhofen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande, Brazil. Hauptthemen laut MEDLINE: Oxidative Stress, Fatty Acids, Inflammation. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Deficiencies in enzymes and transporters involved in mitochondrial fatty acid beta oxidation results in the accumulation of fatty acids, a condition known as fatty acid oxidation disorders (FAODs). Therefore, the present study aimed to evaluate the oxidative and inflammatory profiles of treated patients with FAODs, comparing those receiving dietary treatment and l ‐carnitine supplementation with one untreated FAOD patient, to provide new insights into the pathophysiology and treatment of this group of diseases. Samples from 12 treated FAOD patients, 18 age‐matched controls, and one untreated patient at diagnosis were included in the study. Levels of 8‐isoprostanes, DNA and RNA oxidative damage, nitrite and nitrate, cathepsin D and cytokines were measured in urine and/or plasma samples, depending on the analyte, of FAODs patients under treatment (mean: 3.0 ± 2.9 years) and of an untreated patient with increased levels of several organic acids, who was included as an illustrative case and not considered in the statistical analyses. Levels of 8‐isoprostanes, nitrite and nitrate, DNA damage, and interleukins 1β, 8, and 10 did not differ significantly between treated patients and control group, whereas IL‐6 levels were increased in FAODs patients. These findings indicate that treated FAOD patients presented oxidative and inflammatory biomarker levels similar to those of controls for most analytes, while IL‐6 remained elevated. The results suggest a potential beneficial effect of current treatment on oxidative and inflammatory profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande, Brazil.
- Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande, Brazil.
ORCID-Profile: Stefani Altenhofen, Luísa Tedesco, Franciele Fátima Lopes, Bianca Gomes Dos Reis, Luiza Wailer, Debora Tonelotto, Ana Kalise Bottcher
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Altenhofen, S., Tedesco, L., Lopes, F. F., Acosta, M., Sitta, Â., Coelho, D. M., Reis, B. G. D., Wailer, L., Tonelotto, D., Bottcher, A. K., Wajner, M., & Vargas, C. R. (2026). Inflammation and Oxidative Damage in Fatty Acids Oxidation Disorders. Cell Biochemistry and Function, 44(11). https://doi.org/10.1002/cbf.70328
Vancouver
Altenhofen S, Tedesco L, Lopes FF, Acosta M, Sitta Â, Coelho DM, et al. Inflammation and Oxidative Damage in Fatty Acids Oxidation Disorders. Cell Biochemistry and Function. 2026;44(11). doi:10.1002/cbf.70328
BibTeX
@article{Altenhofen2026,
author = {Altenhofen, Stefani and Tedesco, Luísa and Lopes, Franciele Fátima and Acosta, Marina and Sitta, Ângela and Coelho, Daniella de Moura and Reis, Bianca Gomes Dos and Wailer, Luiza and Tonelotto, Debora and Bottcher, Ana Kalise and Wajner, Moacir and Vargas, Carmen Regla},
title = {Inflammation and Oxidative Damage in Fatty Acids Oxidation Disorders},
journal = {Cell Biochemistry and Function},
year = {2026},
volume = {44},
number = {11},
doi = {10.1002/cbf.70328}
}
EUVIMED